![Biochemical Modulation of Aracytidine (Ara-C) Effects by GTI-2040, a Ribonucleotide Reductase Inhibitor, in K562 Human Leukemia Cells | SpringerLink Biochemical Modulation of Aracytidine (Ara-C) Effects by GTI-2040, a Ribonucleotide Reductase Inhibitor, in K562 Human Leukemia Cells | SpringerLink](https://media.springernature.com/lw685/springer-static/image/art%3A10.1208%2Fs12248-010-9246-5/MediaObjects/12248_2010_9246_Fig1_HTML.gif)
Biochemical Modulation of Aracytidine (Ara-C) Effects by GTI-2040, a Ribonucleotide Reductase Inhibitor, in K562 Human Leukemia Cells | SpringerLink
![Ribonucleotide reductase inhibitors suppress SAMHD1 ara‐CTPase activity enhancing cytarabine efficacy | EMBO Molecular Medicine Ribonucleotide reductase inhibitors suppress SAMHD1 ara‐CTPase activity enhancing cytarabine efficacy | EMBO Molecular Medicine](https://www.embopress.org/cms/asset/6015fbe9-6a9c-47cd-b865-a63f71eaf3a4/emmm201910419-fig-0001-m.jpg)
Ribonucleotide reductase inhibitors suppress SAMHD1 ara‐CTPase activity enhancing cytarabine efficacy | EMBO Molecular Medicine
![ARA depletion experiments and comparative cell assays. (a) Numbers of... | Download Scientific Diagram ARA depletion experiments and comparative cell assays. (a) Numbers of... | Download Scientific Diagram](https://www.researchgate.net/publication/308698726/figure/fig6/AS:668789804900352@1536463323028/ARA-depletion-experiments-and-comparative-cell-assays-a-Numbers-of-oligomers-detected_Q640.jpg)
ARA depletion experiments and comparative cell assays. (a) Numbers of... | Download Scientific Diagram
![Ara-C increases gastric cancer cell invasion by upregulating CD-147-MMP-2/MMP‑9 via the ERK signaling pathway Ara-C increases gastric cancer cell invasion by upregulating CD-147-MMP-2/MMP‑9 via the ERK signaling pathway](https://www.spandidos-publications.com/article_images/or/33/4/OR-33-04-2045-g03.jpg)
Ara-C increases gastric cancer cell invasion by upregulating CD-147-MMP-2/MMP‑9 via the ERK signaling pathway
Chemotherapy-induced differential cell cycle arrest in B-cell lymphomas affects their sensitivity to Wee1 inhibition | Haematologica
Kirawan_ pharmacy - ARA-CELL (حقن السيتارابين) يستخدم لعلاج بعض الأورام الخبيثة والسرطانات مثل اللوكيميا او سرطان الدم،،كما يستخدم لعلاج اللوكيميا المرتبطة بالتهابات السحايا واللوكيميا الحادة وسرطانات الغدد الليمفاوية و الليمفوما ،،ويمكن استخدامه
![Molecules | Free Full-Text | Exploring the Antitumor Mechanism of High-Dose Cytarabine through the Metabolic Perturbations of Ribonucleotide and Deoxyribonucleotide in Human Promyelocytic Leukemia HL-60 Cells | HTML Molecules | Free Full-Text | Exploring the Antitumor Mechanism of High-Dose Cytarabine through the Metabolic Perturbations of Ribonucleotide and Deoxyribonucleotide in Human Promyelocytic Leukemia HL-60 Cells | HTML](https://www.mdpi.com/molecules/molecules-22-00499/article_deploy/html/images/molecules-22-00499-g001.png)
Molecules | Free Full-Text | Exploring the Antitumor Mechanism of High-Dose Cytarabine through the Metabolic Perturbations of Ribonucleotide and Deoxyribonucleotide in Human Promyelocytic Leukemia HL-60 Cells | HTML
![Ara h 2 peptides containing dominant CD4+ T-cell epitopes: Candidates for a peanut allergy therapeutic - Journal of Allergy and Clinical Immunology Ara h 2 peptides containing dominant CD4+ T-cell epitopes: Candidates for a peanut allergy therapeutic - Journal of Allergy and Clinical Immunology](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/7d69528e-b6cd-4e83-bbf6-1442af8859af/gr1.jpg)
Ara h 2 peptides containing dominant CD4+ T-cell epitopes: Candidates for a peanut allergy therapeutic - Journal of Allergy and Clinical Immunology
![Radotinib enhances cytarabine (Ara-C)-induced acute myeloid leukemia cell death | BMC Cancer | Full Text Radotinib enhances cytarabine (Ara-C)-induced acute myeloid leukemia cell death | BMC Cancer | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs12885-020-07701-8/MediaObjects/12885_2020_7701_Fig6_HTML.png)
Radotinib enhances cytarabine (Ara-C)-induced acute myeloid leukemia cell death | BMC Cancer | Full Text
![Molecules | Free Full-Text | Exploring the Antitumor Mechanism of High-Dose Cytarabine through the Metabolic Perturbations of Ribonucleotide and Deoxyribonucleotide in Human Promyelocytic Leukemia HL-60 Cells | HTML Molecules | Free Full-Text | Exploring the Antitumor Mechanism of High-Dose Cytarabine through the Metabolic Perturbations of Ribonucleotide and Deoxyribonucleotide in Human Promyelocytic Leukemia HL-60 Cells | HTML](https://www.mdpi.com/molecules/molecules-22-00499/article_deploy/html/images/molecules-22-00499-g002.png)
Molecules | Free Full-Text | Exploring the Antitumor Mechanism of High-Dose Cytarabine through the Metabolic Perturbations of Ribonucleotide and Deoxyribonucleotide in Human Promyelocytic Leukemia HL-60 Cells | HTML
![Radotinib enhances cytarabine (Ara-C)-induced acute myeloid leukemia cell death | BMC Cancer | Full Text Radotinib enhances cytarabine (Ara-C)-induced acute myeloid leukemia cell death | BMC Cancer | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs12885-020-07701-8/MediaObjects/12885_2020_7701_Fig5_HTML.png)